globenewswire

LeMaitre Vascular Announces Q2 2020 Financial Results Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 11:25
BURLINGTON, Mass., July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 11:02
GAITHERSBURG, Md. and MORRISVILLE, N.C., July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
Cytokinetics to Announce Second Quarter Results on August 6, 2020 Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 11:00
SOUTH SAN FRANCISCO, Calif., July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
Allovate Therapeutics Extends Free Allerdent® Program Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 10:37
New York, July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
Healthcare Personal Protective Equipment Market for COVID-19 to reach USD 25.66 billion by 2027; Increasing Importance of Personal Hygiene and Safety to Augment Growth, Says Fortune Business Insights™ Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 05:08
Pune, July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
LogistiCare Partners with Philabundance and The Liberti Church Network to Deliver Food to Philadelphia Residents In Need Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 05:00
Philadelphia, PA, July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
Scapa Healthcare Closes 2020 Fiscal Year with Resilient Operational Performance Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 05:00
WINDSOR, Conn., July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
MediXall Group Announces Upcoming Launch of Health Karma Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 04:53
Fort Lauderdale, FL, July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
Alfasigma USA, Inc. Engages Indegene, Inc. to Expand the Promotion of ZELNORM® to Healthcare Professionals in the United States Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 04:30
BEDMINSTER, N.J., July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
Highmark Interactive and University at Buffalo Partner to Implement the First FDA Cleared, Gamified Brain Tech in NCAA Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 04:15
TORONTO, July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
FAT Brands’ Elevation Burger Enters the Smithsonian’s National Zoo Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 04:00
Ethical and Sustainable; the “Better for you” Burger Joint Comes to the Nation’s Capital Washington DC, July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
Parexel Expands Global Regulatory Capabilities with Experts from FDA, EMA, NMPA and Spanish AEMPS Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 04:00
BOSTON and DURHAM, N.C., July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
Study finds HFCWO Therapy using Philips InCourage System reduces hospitalizations Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 04:00
July 23, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of a peer-reviewed, retrospective outcomes study demonstrating that, in the first year of use, high frequency chest wall oscillation therapy (HFCWO) using the Philips InCourage System reduced the rate of chronic respiratory patient hospitalization by more than 50 percent. According to the study, antibiotic use also decreased significantly. The study examined data from a registry of adult bronchiectasis patients’ self-reported outcomes collected by RespirTech, a Philips company. This data repository is now the largest bronchiectasis research registry in the world. According to the American Lung Association, nearly 37 million U.S. adults live with a chronic respiratory disease, including cystic fibrosis, chronic obstructive pulmonary disease (COPD), and bronchiectasis [1]. Exacerbations of these chronic respiratory diseases can be a major source of costs for healthcare systems and insurers, as hospitalizations and readmissions result in billions of dollars of additional healthcare costs each year. Such exacerbations have a negative impact on quality of life, as patients experiencing numerous episodes report symptoms such as low energy, shortness of breath, and excess mucus production. This study observed chronic respiratory patients receiving HFCWO therapy, an airway clearance technique that uses a fitted vest to apply external chest wall oscillations in an attempt to combat these issues. The study, “
Read more...
 
Supervisory Board of Biofrontera AG renews Management Board appointment Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 03:30
Leverkusen, Germany, July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
BioSig Technologies to Participate in LD Micro’s Zooming with LD Print E-mail
By GLOBE NEWSWIRE   
Thursday, 23 July 2020 03:30
Westport, CT, July 23, 2020 (GLOBE NEWSWIRE)
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 10 of 170

Newsletter